Generation Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth %
- Profit Growth -3.87%
- Ebitda -3.87%
- Net Worth -19.78%
- Total Assets -19.10%
About Generation Lifescience
Generation Lifescience Private Limited (GLPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 November 2016 (Eight years and two months 19 days old ). Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sahadeb Chowdhury, Naba Saha, Souvik Pramanick, and One other member serve as directors at the Company.
Company Details
-
Location
24 Parganas, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999WB2016PTC218381
-
Company No.
218381
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Nov 2016
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Generation Lifescience?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sahadeb Chowdhury
|
Director | 22-Nov-2016 | Current |
|
Naba Saha
|
Director | 22-Nov-2016 | Current |
|
Souvik Pramanick
|
Additional Director | 08-Feb-2017 | Current |
|
Saikat Das
|
Additional Director | 08-Feb-2017 | Current |
Financial Performance of Generation Lifescience.
Generation Lifescience Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 3.87% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Generation Lifescience?
In 2020, Generation Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Gold-Reel Production & Entertainment LimitedSahadeb Chowdhury is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Generation Lifescience?
Unlock and access historical data on people associated with Generation Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Generation Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Generation Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.